ASAIO Journal · 1979 · 24 citations · 0 references
MedicinePharmacokineticsPharmacologyDialysisNeuropharmacologyPharmacodynamicsDopaminergic PharmacologyPeritoneal DialysisRenal Blood FlowRenal ClearanceRenal Drug ClearanceRenal PharmacologyAlpha-1 Adrenergic BlockadeAlpha-adrenergic AgonistsBlood FlowCatecholamine InfusionsDrug Clearance During Peritoneal DialysisIntraperitoneal AdministrationPeritoneal Dialysis CarePeritoneal Membrane Transport
In rabbits, intravenous vasopressor doses of dopamine augmented peritoneal clearances of creatinine and urea, suggesting increased mesenteric blood flow and possibly augmented permeability. Intraperitoneal dopamine also accelerated peritoneal transport of urea. Solute transport across the peritoneum was decreased by intravenous infusion of 1-norepinephrine. Intraperitoneal administration of the alpha-adrenergic antagonist phentolamine partially abolished the augmentation of peritoneal clearances induced by intravenous dopamine. The results suggest that in patients undergoing peritoneal dialysis who require vasopressor therapy, dopamine should be preferred to norepinephrine.